Elkarrekintza farmakologikoak @page { } table { border-collapse:collapse; border-spacing:0; empty-cells:show } td, th { vertical-align:top; font-size:12pt;} h1, h2, h3, h4, h5, h6 { clear:both } ol, ul { margin:0; padding:0;} li { list-style: none; margin:0; padding:0;} <!-- "li span.odfLiEnd" - IE 7 issue--> li span. { clear: both; line-height:0; width:0; height:0; margin:0; padding:0; } span.footnodeNumber { padding-right:1em; } span.annotation_style_by_filter { font-size:95%; font-family:Arial; background-color:#fff000; margin:0; border:0; padding:0; } * { margin:0;} .gr1 { color:#ffffff; font-size:18pt; font-style:normal; font-weight:normal; line-height:100%; margin-bottom:0cm; margin-left:0cm; margin-right:0cm; margin-top:0cm; padding-bottom:0.125cm; padding-left:0.25cm; padding-right:0.25cm; padding-top:0.125cm; text-align:left ! important; text-indent:0cm; text-shadow:none; text-decoration:none ! important; writing-mode:lr-tb; min-height:1.27cm;} .gr10 { color:#ffffff; font-size:18pt; font-style:normal; font-weight:normal; line-height:100%; margin-bottom:0cm; margin-left:0cm; margin-right:0cm; margin-top:0cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; padding-top:0.13cm; text-align:left ! important; text-indent:0cm; text-shadow:none; text-decoration:none ! important; writing-mode:lr-tb; } .gr11 { font-size:24pt; writing-mode:lr-tb; } .gr12 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .gr13 { color:#ffffff; font-size:18pt; font-style:normal; font-weight:normal; line-height:100%; margin-bottom:0cm; margin-left:0cm; margin-right:0cm; margin-top:0cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; padding-top:0.13cm; text-align:left ! important; text-indent:0cm; text-shadow:none; text-decoration:none ! important; writing-mode:lr-tb; } .gr14 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .gr15 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .gr2 { color:#ffffff; font-size:18pt; font-style:normal; font-weight:normal; line-height:100%; margin-bottom:0cm; margin-left:0cm; margin-right:0cm; margin-top:0cm; padding-bottom:0.125cm; padding-left:0.25cm; padding-right:0.25cm; padding-top:0.125cm; text-align:left ! important; text-indent:0cm; text-shadow:none; text-decoration:none ! important; writing-mode:lr-tb; min-height:1.27cm;} .gr3 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .gr4 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .gr5 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .gr6 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .gr7 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .gr8 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .gr9 { font-size:24pt; writing-mode:lr-tb; padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; } .P1 { font-size:14pt; } .P10 { margin-left:0cm; margin-right:0cm; text-indent:0cm; } .P11 { text-align:center ! important; writing-mode:lr-tb; } .P12 { margin-left:0.952cm; margin-right:0cm; margin-top:0.282cm; margin-bottom:0cm; text-align:center ! important; text-indent:-0.952cm; } .P13 { margin-left:0cm; margin-right:0cm; margin-top:0.176cm; margin-bottom:0cm; text-indent:0cm; } .P14 { margin-left:0.952cm; margin-right:0cm; margin-top:0.176cm; margin-bottom:0cm; text-align:center ! important; text-indent:-0.952cm; } .P15 { margin-left:0cm; margin-right:0cm; margin-top:0.246cm; margin-bottom:0cm; text-indent:0cm; } .P16 { margin-left:0cm; margin-right:0cm; margin-top:1.058cm; margin-bottom:0cm; text-indent:0cm; } .P17 { margin-left:0cm; margin-right:0cm; margin-top:0.211cm; margin-bottom:0cm; line-height:90%; text-indent:0cm; } .P18 { margin-left:0cm; margin-right:0cm; margin-top:0.617cm; margin-bottom:0cm; text-indent:0cm; } .P19 { margin-left:0cm; margin-right:0cm; margin-top:0cm; margin-bottom:0cm; line-height:100%; text-indent:0cm; } .P2 { text-align:right ! important; font-size:14pt; } .P20 { margin-left:0cm; margin-right:0cm; margin-top:0cm; margin-bottom:0cm; line-height:100%; text-indent:0cm; } .P21 { margin-left:0cm; margin-right:0cm; margin-top:0cm; margin-bottom:0cm; line-height:100%; text-align:justify ! important; text-indent:0cm; } .P22 { margin-left:0cm; margin-right:0cm; margin-top:0cm; margin-bottom:0cm; line-height:100%; text-align:justify ! important; text-indent:0cm; } .P23 { margin-left:0cm; margin-right:0cm; line-height:100%; text-align:justify ! important; text-indent:0cm; } .P24 { margin-left:0cm; margin-right:0cm; line-height:100%; text-align:justify ! important; text-indent:0cm; } .P25 { margin-left:0cm; margin-right:0cm; line-height:100%; text-indent:0cm; } .P26 { margin-left:0cm; margin-right:0cm; margin-top:0.846cm; margin-bottom:0cm; text-indent:0cm; } .P27 { margin-left:0cm; margin-right:0cm; margin-top:0.211cm; margin-bottom:0cm; text-indent:0cm; } .P28 { margin-left:2.063cm; margin-right:0cm; margin-top:0.211cm; margin-bottom:0cm; text-indent:-0.793cm; } .P29 { margin-left:0cm; margin-right:0cm; margin-top:0.846cm; margin-bottom:0cm; line-height:100%; text-indent:0cm; } .P3 { writing-mode:lr-tb; } .P30 { margin-left:0cm; margin-right:0cm; margin-top:0.211cm; margin-bottom:0cm; line-height:100%; text-indent:0cm; } .P31 { margin-left:0cm; margin-right:0cm; margin-top:0.246cm; margin-bottom:0cm; line-height:80%; text-indent:0cm; } .P32 { margin-left:0cm; margin-right:0cm; margin-top:0.211cm; margin-bottom:0cm; line-height:80%; text-indent:0cm; } .P33 { margin-left:0cm; margin-right:0cm; margin-top:0.176cm; margin-bottom:0cm; line-height:80%; text-indent:0cm; } .P4 { margin-left:0cm; margin-right:0cm; line-height:100%; text-indent:0cm; } .P5 { margin-left:0cm; margin-right:0cm; line-height:100%; text-indent:0cm; writing-mode:lr-tb; } .P6 { margin-left:0cm; margin-right:0cm; line-height:100%; text-align:center ! important; text-indent:0cm; } .P7 { margin-left:0cm; margin-right:0cm; line-height:100%; text-align:center ! important; text-indent:0cm; writing-mode:lr-tb; } .P8 { margin-left:0cm; margin-right:0cm; line-height:100%; text-align:right ! important; text-indent:0cm; } .P9 { margin-left:0cm; margin-right:0cm; line-height:100%; text-align:right ! important; text-indent:0cm; writing-mode:lr-tb; } .ce1 { padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; margin-left:0cm; margin-right:0cm; margin-top:0cm; margin-bottom:0cm; line-height:100%; text-indent:0cm; border-style:none; } .ce10 { padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; margin-left:0cm; margin-right:0cm; line-height:100%; text-align:justify ! important; text-indent:0cm; border-style:none; } .ce11 { padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; margin-left:0cm; margin-right:0cm; line-height:100%; text-indent:0cm; border-style:none; } .ce12 { padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; margin-left:0cm; margin-right:0cm; line-height:100%; text-align:justify ! important; text-indent:0cm; border-style:none; } .ce13 { padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; margin-left:0cm; margin-right:0cm; line-height:100%; text-indent:0cm; border-style:none; } .ce14 { padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; margin-left:0cm; margin-right:0cm; line-height:100%; text-indent:0cm; border-style:none; } .ce15 { padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; margin-left:0cm; margin-right:0cm; line-height:100%; text-indent:0cm; border-style:none; } .ce16 { padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; margin-left:0cm; margin-right:0cm; line-height:100%; text-align:justify ! important; text-indent:0cm; border-style:none; } .ce17 { padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; margin-left:0cm; margin-right:0cm; line-height:100%; text-align:center ! important; text-indent:0cm; border-style:none; } .ce18 { padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; margin-left:0cm; margin-right:0cm; line-height:100%; text-align:center ! important; text-indent:0cm; border-style:none; } .ce19 { padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; margin-left:0cm; margin-right:0cm; line-height:100%; text-align:justify ! important; text-indent:0cm; border-style:none; } .ce2 { padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; margin-left:0cm; margin-right:0cm; margin-top:0cm; margin-bottom:0cm; line-height:100%; text-indent:0cm; border-style:none; } .ce20 { padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; margin-left:0cm; margin-right:0cm; line-height:100%; text-indent:0cm; border-style:none; } .ce3 { padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; margin-left:0cm; margin-right:0cm; margin-top:0cm; margin-bottom:0cm; line-height:100%; text-indent:0cm; border-style:none; } .ce4 { padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; margin-left:0cm; margin-right:0cm; margin-top:0cm; margin-bottom:0cm; line-height:100%; text-align:justify ! important; text-indent:0cm; border-style:none; } .ce5 { padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; margin-left:0cm; margin-right:0cm; line-height:100%; text-align:center ! important; text-indent:0cm; border-style:none; } .ce6 { padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; margin-left:0cm; margin-right:0cm; line-height:100%; text-align:center ! important; text-indent:0cm; border-style:none; } .ce7 { padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; margin-left:0cm; margin-right:0cm; line-height:100%; text-align:center ! important; text-indent:0cm; border-style:none; } .ce8 { padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; margin-left:0cm; margin-right:0cm; line-height:100%; text-align:justify ! important; text-indent:0cm; border-style:none; } .ce9 { padding-top:0.13cm; padding-bottom:0.13cm; padding-left:0.25cm; padding-right:0.25cm; margin-left:0cm; margin-right:0cm; line-height:100%; text-align:justify ! important; text-indent:0cm; border-style:none; } .co1 { width:9.197cm; } .co2 { width:7.802cm; } .co3 { width:4.254cm; } .co4 { width:7.902cm; } .co5 { width:10.289cm; } .co6 { width:7.01cm; } .co7 { width:6.791cm; } .ro1 { height:1.108cm; } .ro2 { height:16.332cm; } .ro3 { height:1.955cm; } .ro4 { height:2.802cm; } .ro5 { height:3.649cm; } .ro6 { height:1.414cm; } .ro7 { height:11.188cm; } .T1 { color:#ffffff; font-size:12pt; } .T10 { font-size:24pt; } .T11 { color:#ff0000; font-size:24pt; font-weight:bold; } .T12 { color:#b9efee; font-size:54pt; } .T13 { font-size:36pt; } .T14 { color:#ff0000; font-size:20pt; text-shadow:none; font-weight:bold; } .T15 { color:#ffffff; font-size:20pt; text-shadow:none; } .T16 { color:#ffffff; font-size:20pt; font-style:italic; text-shadow:none; } .T17 { color:#ffffff; font-size:20pt; font-weight:bold; } .T18 { color:#ffffff; font-size:20pt; font-style:italic; } .T19 { color:#ffffff; font-size:20pt; } .T2 { color:#b9efee; font-size:54pt; } .T20 { color:#ffffff; font-size:20pt; } .T21 { color:#b2b2b2; } .T22 { font-style:italic; } .T23 { font-size:32pt; } .T24 { font-size:24pt; font-style:italic; } .T25 { font-size:36pt; } .T26 { color:#ffff66; font-size:28pt; font-weight:bold; } .T27 { font-size:24pt; } .T28 { font-size:24pt; font-weight:bold; } .T29 { color:#ffcc00; font-size:28pt; font-weight:bold; } .T30 { color:#ffcc00; font-size:28pt; font-style:italic; font-weight:bold; } .T31 { font-size:24pt; text-decoration:underline; } .T32 { font-size:20pt; } .T33 { font-size:20pt; font-style:italic; } .T5 { text-decoration:underline; } .T6 { font-size:20pt; } .T7 { color:#ffffff; font-size:28pt; } .T8 { color:#ffffff; font-size:24pt; } .T9 { color:#ffffff; font-size:24pt; font-style:italic; } <!-- ODF styles with no properties representable as CSS --> .dp1 .dp2 .dp3 .T3 .T4 { } Eragin kaltegarriak Eragin kaltegarriak“Gaixotasun baten prebentzioa, diagnosia edo tratamendurako behar diren dosietan erabilitako farmako batek sortutako eragin kaltegarri guztiak”•Gaixoarentzat kaltegarriak diren farmakoaren eraginak •Dosiaren murrizketa edo tratamenduaren etenaldia behartuko dute Eragin kaltegarriak•Eragin kolaterala •Eragin sekundarioa •Erreakzio alergikoa •Erreakzio idiosinkrasikoa •Gaindosia •Toxikotasuna Eragin kaltegarriak•Farmakoak hartzen dituen pazienteen % 41-ak eragin kaltegarriak jasango ditu •Larrialdi zerbitzuetako kontsulten % 1-4-ak eragin kaltegarriren bat izango du kausa •Ospitalizazio guztien % 0.2-3-ak eragin kaltegarriren bat izango du kausa •Ospitalean hildako guztien % 0.3-0.9 eragin kaltegarriengatik hilko da Arrisku faktoreakZahartzaroa Umeak Polimedikazioa Automedikazioa Giltzurrunetako gutxiegitasuna Gibeleko gutxiegitasuna Tarte terapeutiko estua duten farmakoak Elkarrekintza ugari duten farmakoak Eragin kaltegarri ugari duten farmakoak Elkarrekintza farmakologikoak Elkarrekintzak sortzeko joera handiagoa duten farmakoak–Proteina plasmatikoekin biziki lotzen diren farmakoak (AIEE, sulfamidak...) –Beste farmakoen metabolismoa eraldatzen duten farmakoak (antiepileptikoak, IMAO...) Inhibizio entzimatikoaIndukzio entzimatikoa -Aho-bidetiko antisorgailuak -Amiodarona -Azido balproikoa -Berapamilo -Diltiazem -Eritromizina -Fenilbutazona -Flukonazol -Fluoxetina -Fluvoxamina -Itrakonazol -Ketokonazol -Kinidina -Metronidazol -Paroxetina -Zimetidina -Ziprofloxazino -Alkohola -Barbiturikoak -Dexametasona -Errifabutina -Errifanpizina -Fenobarbital -Fenitoina -Griseofulbina -Isoniazida -Karbamazepina -Primidona -Sulfinpirazona FarmakoaInhibitzaileaOndorio klinikoaTerfenadinaAstemizolKetokonazol, ItrakonazolEritromizinaTakikardiaMidazolamDiltiazemKetokonazol, ItrakonazolBerapamilo Sedazio luzeagoa eta gogorragoaZiklosporinaDiltiazemKetokonazol, ItrakonazolBerapamiloEritromizina  toxikotasuna gibelean, NSZeaneta giltzurrunetan Elkarrekintzak sortzeko joera handiagoa duten farmakoak–Proteina plasmatikoekin biziki lotzen diren farmakoak (AIEE, sulfamidak...) –Beste farmakoen metabolismoa eraldatzen duten farmakoak (antiepileptikoak, IMAO...) –Giltzurrunetako funtzioa eraldatzen duten farmakoak (probenezida, diuretikoak...) Elkarrekintzak pairatzeko joera handiagoa duten farmakoak–Malda altuko dosi/erantzuna kurba duten farmakoak –Tarte terapeutiko estua duten farmakoak (aminoglukosidoak, litio, digitalikoak...) –Metabolismo saturagarria duten farmakoak (fenitoina, teofilina...) –Eraginkorrak izateko odol-maila zehatzak behar duten tratamendu kronikoetan erabilitako farmakoak (antiepileptikoak, antiarritmikoak, aho-bidetiko antisorgailuak...) Janariak  Farmakoak •Xurgapenaren atzerapena –Urdailaren hustuketaren atzerapena (zuntza  klindamizina, parazetamola) •Xurgapenaren murrizketa –Urdailaren hustuketaren atzerapena   urdail-azidoarekiko kontaktua (zuntza  lobastatina, digoxina, metformina) urdailaren pH-a (proteinak  indinabir) Janariak  Farmakoak •Xurgapenaren inhibizioa –Erreakzio kimikoak (tetraziklinak + katio dibalenteak)  aktibitate gabeko produktua •Xurgapenaren handitzea  hesteetako likidoaren bolumena + area eta behazun jariaketak (janari koipetsuak  teofilina, espironolaktona) –Urdailaren hustuketaren atzerapena (karbohidratoak  fenitoina)  Hesteetako CYP3A4 entzima (pomelo zukua  felodipino, terfenadina, sakinabir, ziklosporina, midazolam, triazolam, berapamilo) Urdaila hutsikUrdaila betetaIsoniazidaKloranbuziloaLebodopaMelfalanMerkaptopurinaMetotrexatoMidazolamPenizilaminaPenizilinakTetraziklinak ErretinoideakFenitoinaGriseofulbinaKlorokinaLobastatinaNitrofurantoinaZiklosporina •Elkarrekintza arriskutsuak –IMAO-k + tiramina asko duten janariak (gaztak, ardoak, ketuak...)  krisialdi hipertentsiboak •Alkohola –Kronikoa  indukzio entzimatikoa –Akutua  inhibizio entzimatikoa –NSZ-aren depresioa  bentzodiazepinak, barbiturikoak, antihistaminikoak... •Tabakoa –Indukzio metabolikoa  teofilina, takrina, imipramina, haloperidol, pentazozina, propranolol, flekainida, estradiol –Azaleko basouzkurdura  intsulinaren xurgapena –Elkarrekintza farmakodinamikoak (nikotina): -blokeatzaileen eragin hipotentsorea bentzodiazepinek eragindako sedazioa  opioide batzuen eragin analgesikoa (dextropropoxifeno eta pentazozina)
